טוען...
IMMU-20. CHARACTERIZING THE IMMUNE LANDSCAPE OF PD-1/PD-L1 IN BRAIN TUMOR IMMUNE CELL POPULATION USING CyTOF MASS CyTOMETRY
INTRODUCTION: Immunotherapy may be a viable and efficacious treatment strategy for glioblastoma and other brain tumors. However, the negative co-stimulatory molecule PD-1 and its ligand PD-L1, which contributes to T cell inhibition in the tumor context, may limit effective anti-tumor immune response...
שמור ב:
| הוצא לאור ב: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693003/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.478 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|